Antitrust
AbbVie Wins First Round in Humira Antitrust Lawsuit
The purpose of the secondary patent filings was to assemble a thicket of patents, 132 in all, to prohibit competition from biosimilar companies.
AbbVie Wins First Round in Humira Antitrust Lawsuit
